BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 8639848)

  • 1. BCR/ABL-negative primitive progenitors suitable for transplantation can be selected from the marrow of most early-chronic phase but not accelerated-phase chronic myelogenous leukemia patients.
    Verfaillie CM; Bhatia R; Miller W; Mortari F; Roy V; Burger S; McCullough J; Stieglbauer K; Dewald G; Heimfeld S; Miller JS; McGlave PB
    Blood; 1996 Jun; 87(11):4770-9. PubMed ID: 8639848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCR/ABL- CD34(+)HLA-DR- progenitor cells in early chronic phase, but not in more advanced phases, of chronic myelogenous leukemia are polyclonal.
    Delforge M; Boogaerts MA; McGlave PB; Verfaillie CM
    Blood; 1999 Jan; 93(1):284-92. PubMed ID: 9864172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of bcr/abl gene in single hemopoietic progenitors in some patients with chronic myelogenous leukemia.
    Misawa M; Maeda H; Hara H; Yamamoto Y; Furuyama J
    Stem Cells; 1993 Nov; 11(6):536-42. PubMed ID: 7509222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of myeloid progenitors lacking BCR/ABL mRNA in chronic myelogenous leukemia patients after in vitro treatment with the tyrosine kinase inhibitor genistein.
    Carlo-Stella C; Dotti G; Mangoni L; Regazzi E; Garau D; Bonati A; Almici C; Sammarelli G; Savoldo B; Rizzo MT; Rizzoli V
    Blood; 1996 Oct; 88(8):3091-100. PubMed ID: 8874208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection of BCR/ABL-negative stem cells from marrow or blood of patients with chronic myeloid leukemia.
    Guyotat D; Wahbi K; Viallet A; Piselli S; Campos L
    Leukemia; 1999 Jul; 13(7):991-8. PubMed ID: 10400413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of BCR/ABL-negative primitive hematopoietic progenitor cells within chronic myeloid leukemia marrow.
    Leemhuis T; Leibowitz D; Cox G; Silver R; Srour EF; Tricot G; Hoffman R
    Blood; 1993 Feb; 81(3):801-7. PubMed ID: 7679000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BCR/ABL-negative progenitors are enriched in the adherent fraction of CD34+ cells circulating in the blood of chronic phase chronic myeloid leukemia patients.
    Grand FH; Marley SB; Chase A; Titley I; Healy L; Spencer A; Reiter A; Goldman JM; Gordon MY
    Leukemia; 1997 Sep; 11(9):1486-92. PubMed ID: 9305602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose hydroxyurea plus G-CSF mobilize BCR-ABL-negative progenitor cells (CFC, LTC-IC) into the blood of newly diagnosed CML patients at any time of hematopoietic regeneration.
    Petzer AL; Hochenburger E; Haun M; Duba HCh; Grünewald K; Hoflehner E; Sill H; Linkesch W; Gastl G; Gunsilius E
    J Hematother Stem Cell Res; 2002 Apr; 11(2):293-300. PubMed ID: 11983100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BCR-ABL expression in different subpopulations of functionally characterized Ph+ CD34+ cells from patients with chronic myeloid leukemia.
    Maguer-Satta V; Petzer AL; Eaves AC; Eaves CJ
    Blood; 1996 Sep; 88(5):1796-804. PubMed ID: 8781437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection of benign primitive hematopoietic progenitors in chronic myelogenous leukemia on the basis of HLA-DR antigen expression.
    Verfaillie CM; Miller WJ; Boylan K; McGlave PB
    Blood; 1992 Feb; 79(4):1003-10. PubMed ID: 1371077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral blood is a source of BCR-ABL-negative pre-progenitors in early chronic phase chronic myeloid leukemia.
    Lewis ID; Haylock DN; Moore S; To LB; Hughes TP
    Leukemia; 1997 Apr; 11(4):581-7. PubMed ID: 9096699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of autografting in chronic myelogenous leukemia: effects of priming regimen and marrow or blood origin of stem cells.
    Verfaillie CM; Bhatia R; Steinbuch M; DeFor T; Hirsch B; Miller JS; Weisdorf D; McGlave PB
    Blood; 1998 Sep; 92(5):1820-31. PubMed ID: 9716614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular signature of CD34(+) hematopoietic stem and progenitor cells of patients with CML in chronic phase.
    Diaz-Blanco E; Bruns I; Neumann F; Fischer JC; Graef T; Rosskopf M; Brors B; Pechtel S; Bork S; Koch A; Baer A; Rohr UP; Kobbe G; von Haeseler A; Gattermann N; Haas R; Kronenwett R
    Leukemia; 2007 Mar; 21(3):494-504. PubMed ID: 17252012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective expansion of normal haemopoietic progenitors from chronic myelogenous leukaemia marrow.
    Fogli M; Amabile M; Martinelli G; Fortuna A; Rondelli D; Ratta M; Curti A; Tura S; Lemoli RM
    Br J Haematol; 1998 Apr; 101(1):119-29. PubMed ID: 9576192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation at single cell level of residual Philadelphia negative hemopoietic stem cells in chronic phase CML patients.
    Akel S; Kolialexi A; Mavrou A; Metaxotou C; Loukopoulos D; Yataganas X
    Cancer Genet Cytogenet; 2000 Oct; 122(2):93-100. PubMed ID: 11106818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of primitive subpopulations of normal and leukemic cells present in the blood of patients with newly diagnosed as well as established chronic myeloid leukemia.
    Petzer AL; Eaves CJ; Lansdorp PM; Ponchio L; Barnett MJ; Eaves AC
    Blood; 1996 Sep; 88(6):2162-71. PubMed ID: 8822936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukemic burden in subpopulations of CD34+ cells isolated from the mobilized peripheral blood of alpha-interferon-resistant or -intolerant patients with chronic myeloid leukemia.
    Van den Berg D; Wessman M; Murray L; Tong J; Chen B; Chen S; Simonetti D; King J; Yamasaki G; DiGiusto R; Gearing D; Reading C
    Blood; 1996 May; 87(10):4348-57. PubMed ID: 8639795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinically suitable ex vivo expansion culture system for LTC-IC and CFC using stroma-conditioned medium.
    Bhatia R; McGlave PB; Miller JS; Wissink S; Lin WN; Verfaillie CM
    Exp Hematol; 1997 Aug; 25(9):980-91. PubMed ID: 9257812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic myelogenous leukemia primitive hematopoietic progenitors demonstrate increased sensitivity to growth factor-induced proliferation and maturation.
    Bhatia R; Munthe HA; Williams AD; Zhang F; Forman SJ; Slovak ML
    Exp Hematol; 2000 Dec; 28(12):1401-12. PubMed ID: 11146162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic heterogeneity of primitive leukemic hematopoietic cells in patients with chronic myeloid leukemia.
    Udomsakdi C; Eaves CJ; Lansdorp PM; Eaves AC
    Blood; 1992 Nov; 80(10):2522-30. PubMed ID: 1384787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.